Chronic Kidney Disease
Conditions
Interventions
Standard dose daily maintenance treatment group:Daily standard dose vitamin D2 treatment
Standard dose weekly shock treatment group:Weekly standard dose vitamin D2 shock therapy
Blank control group:Continuation of the original treatment programme
Low-dose daily maintenance treatment group:Daily low-dose vitamin D2 treatment
Sponsors
Emergency General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult ESRD patients receiving MHD treatment in our hospital have been undergoing MHD for no less than 3 months.
Exclusion criteria
Exclusion criteria: 1. Clinical data is incomplete, lacking key clinical data such as serum 25(OH)D; 2. Recent acute cardiovascular and cerebrovascular events; 3. Recent severe infections; 4. Coexisting malignant tumors, tuberculosis infections, and other chronic wasting diseases; 5. Unable to effectively cooperate to complete the relevant assessment projects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 4-metre walking speed, 30-second starting experiments;Grip strength;Serum type III procollagen amino-terminal peptide;Upper arm and calf circumference;Skeletal muscle mass; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood calcium, blood phosphorus, parathyroid hormone;25(OH)D3; | — |
Countries
China
Contacts
Public ContactZhaoxing Wang
Emergency General Hospital
Outcome results
None listed